164 related articles for article (PubMed ID: 22528910)
1. Utility of FDG PET/CT in the assessment of myeloid sarcoma.
Lee EY; Anthony MP; Leung AY; Loong F; Khong PL
AJR Am J Roentgenol; 2012 May; 198(5):1175-9. PubMed ID: 22528910
[TBL] [Abstract][Full Text] [Related]
2. (18)F-FDG PET/CT for detection of leukemic transformation in myelofibrosis.
Derlin T; Clauditz TS; Kröger N
Clin Nucl Med; 2015 Jun; 40(6):521-2. PubMed ID: 25674874
[TBL] [Abstract][Full Text] [Related]
3. FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
Niu N; Cui R; Li F
Clin Nucl Med; 2016 Mar; 41(3):235-6. PubMed ID: 26505855
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT of Primary Cervical Granulocytic Sarcoma.
Zheng LC; OuYang XL; Zhang WJ; Liu GC; Zhang XM
Clin Nucl Med; 2015 Nov; 40(11):917-8. PubMed ID: 26252324
[TBL] [Abstract][Full Text] [Related]
5. Utility of 18F-FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient.
Lee EY; Leung AY; Anthony MP; Loong F; Khong PL
Am J Hematol; 2011 Dec; 86(12):1036-7. PubMed ID: 21800353
[No Abstract] [Full Text] [Related]
6. ¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
Stölzel F; Röllig C; Radke J; Mohr B; Platzbecker U; Bornhäuser M; Paulus T; Ehninger G; Zöphel K; Schaich M
Haematologica; 2011 Oct; 96(10):1552-6. PubMed ID: 21685468
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose PET/CT-Guided Palliative Radiotherapy Provides Durable Responses to Over a Dozen Sites of Disease in Relapsed Myeloid Sarcoma.
Shuttleworth C; Wegner EA; Thompson SR; Kidson-Gerber G
Clin Nucl Med; 2020 Nov; 45(11):886-887. PubMed ID: 32804769
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy.
Yagi T; Ishikawa J; Takahashi M; Yamashita Y; Kusakabe S; Yoshinami T; Masaie H; Sugimoto N; Yoshida H; Imamura F
Intern Med; 2012; 51(7):769-72. PubMed ID: 22466836
[TBL] [Abstract][Full Text] [Related]
9. Myeloid sarcoma presenting as an anterior mediastinal mass invading the pericardium: Serial Imaging With F-18 FDG PET/CT.
Makis W; Hickeson M; Derbekyan V
Clin Nucl Med; 2010 Sep; 35(9):706-9. PubMed ID: 20706048
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
12. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT Findings of Myeloid Sarcoma in the Pancreas.
Filizoglu N; Ozguven S
Clin Nucl Med; 2022 Jan; 47(1):e52-e53. PubMed ID: 34034332
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
15. Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.
Sharma P; Jain TK; Singh H; Suman SK; Faizi NA; Kumar R; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2013 Mar; 34(3):211-9. PubMed ID: 23353886
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
17. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
18. Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma. Initial results.
Aschoff P; Häntschel M; Oksüz M; Werner MK; Lichy M; Vogel W; Pfannenberg C
Nuklearmedizin; 2009; 48(5):185-91. PubMed ID: 19710955
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus.
Kim JW; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2013 May; 49(5):449-53. PubMed ID: 23321549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
